OR 09 - Istaroxime follow-on compounds: a new class of selective SERCA2a activators as first-in-class drug candidates for heart failure treatment
Event:
47th EWGCCE Meeting 2023
Topic:
Cellular Electrophysiology
Session:
Session 4: Pharmacology of Ion Channels
